发明名称 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15
摘要 To provide a method of detecting abnormal bone metabolism by using a gene strongly expressed in an osteoclast; a method of screening a compound having a therapeutic and/or preventive effect on abnormal bone metabolism; and a pharmaceutical composition for treating and/or preventing abnormal bone metabolism. Provision of a method of detecting abnormal bone metabolism by using the expression of human Siglec-15 gene as an index; a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation; and the like.
申请公布号 US2012230988(A1) 申请公布日期 2012.09.13
申请号 US201213481016 申请日期 2012.05.25
申请人 HIRUMA YOSHIHARU;TSUDA EISUKE;DAIICHI SANKYO COMPANY, LIMITED 发明人 HIRUMA YOSHIHARU;TSUDA EISUKE
分类号 A61K39/395;A61P19/08;A61P19/10;A61P35/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址